Chinese Journal of Integrative Medicine

, Volume 20, Issue 8, pp 618–623

Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line

Original Article

Abstract

Objective

To investigate the possible mechanism through which Artemisinin induced apoptosis in pancreatic cell line.

Methods

Column chromatography, thin layer chromatography (TLC) and proton NMR spectroscopy were used to purify Artemisinin. The flowcytometry was employed to detect apoptosis and reactive oxygen species (ROS).

Results

The results indicated that 50% inhibiting concentration (IC50 value) for pancreatic cell line (RIN) was 45 μmol/L of Artemisinin. Artemisinin had no cytotoxic effect on the growth of peripheral blood lymphocytes. The mechanism of apoptosis was evaluated by measuring intracellular ROS. It was shown that Artemisinin-induced apoptosis occurred independently of the binding of CD95L to CD95 receptor in the RIN cells. Moreover, Artemisinin, in a dose-dependent manner, could significantly increase the level of ROS.

Conclusion

Artemisinin can induce apoptosis in the RIN cells via the generation of ROS and triggering the intrinsic pathway of cell death.

Keywords

Artemisinin endoperoxide bridge apoptosis reactive oxygen species 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klayman DL. Qinghaosu (Artemisinin): an antimalarial drug from China. Science 1985;228:1049–1055.PubMedCrossRefGoogle Scholar
  2. 2.
    Luo Z, Shen C. The chemistry, pharmacology, and clinical applications of qinghaosu (Artemisinin) and its derivatives. Med Res Rev 1987;7:29–52.PubMedCrossRefGoogle Scholar
  3. 3.
    Borstnik K, Paik I, Posner G. Malaria: new chemotherapeutic peroxide drugs. Mini-Reviews in Medicinal Chemistry 2002;2:573–583.PubMedCrossRefGoogle Scholar
  4. 4.
    Meshnick S, Yang Y, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent Artemisinin (qinghaosu). Antimicrob Agents Chemother 1993;37:1108–1114.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    O’Neill P, Posner G. A medicinal chemistry perspective on artemisinin and related endoperoxides. J Med Chem 2004;47:2945–2964.PubMedCrossRefGoogle Scholar
  6. 6.
    Robert A, Coppel Y, Meunier B. A lkylation of heme by the antimalarial drug Artemisinin. Chem Commun 2002;5:414–415.CrossRefGoogle Scholar
  7. 7.
    Sanjeev K, Anne-Catrin U, Richard KH. Artemisinins: mechanisms of action and potential for resistance. Drug Resistance Updates 2004;7:233–244.CrossRefGoogle Scholar
  8. 8.
    Nathawut S, Rachanee U, Anake K, Udom C, Samlee M. Redox reaction of Artemisinin with ferrous and ferric ions in aqueous buffer. Chem Pharm Bull 2001;49:1541–1546.CrossRefGoogle Scholar
  9. 9.
    Asawamahasakda W, Ittarat I, Pu Y, Ziffer H, Meshnick S. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob Agents Chemother 1994;38:1854–1858.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456–1462.PubMedCrossRefGoogle Scholar
  11. 11.
    Soini Y, Paakko P, Lehto V. Histopathological evaluation of apoptosis in cancer. Am J Pathol 1998;153:1041–1053.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Chick W, Warren S, Chute R, Like A, Lauris V, Kitchen K. A transplantable insulinoma in the rat. Proc Natl Acad Sci USA 1977;74:628–632.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar C:The anti-malarial artesunate is also active against cancer. Int J Oncol 2001;18:767–773.PubMedGoogle Scholar
  14. 14.
    Efferth T, Davey M, Olbrich A, Rücher G, Gebbart E, Daveu R. Activity of drugs from traditional Chinese medicine towards sensitive and MDRI- or MRPI-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol Dis 2002;28:160–168.PubMedCrossRefGoogle Scholar
  15. 15.
    Berman P, Adams P. Artemisinin enhances hemecatalysed oxidation of lipid membranes. Free Radic Bio Med 1997;22:1283–1288.CrossRefGoogle Scholar
  16. 16.
    Zhang F, Grosser D, Meshnick S. Hemin-catalyzed decomposition of Artemisinin (qinghaosu). Biochem Pharmacol 1992;43:1805–1809.PubMedCrossRefGoogle Scholar
  17. 17.
    Singh NP, Lai H. Artemisinin induces apoptosis in human cancer cells. Anticancer Research 2004;24:2277–2280.PubMedGoogle Scholar
  18. 18.
    Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, et al. Prediction of sensitivity of esophageal tumor to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 2001;61:6474–6479.PubMedGoogle Scholar
  19. 19.
    Singh N, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 2001;70:49–56.PubMedCrossRefGoogle Scholar
  20. 20.
    Lai H, Singh N. Selective cancer cell cytotoxicity from exposure to dihydro artemisinin and holotransferrin. Cancer Lett 1995;91:41–46.PubMedCrossRefGoogle Scholar
  21. 21.
    Price R, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, et al. Artesunate versus artemether for the treatment of recrudescent multidrug resistant plasmodium falciparum malaria. Am J Trop Med Hyg 1998;59:883–888.PubMedGoogle Scholar
  22. 22.
    Efferth T, Briehl M, Tome M. Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol 2003;23:1231–1235.PubMedGoogle Scholar
  23. 23.
    Meshnick S. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 2002;32:1655–1660.PubMedCrossRefGoogle Scholar
  24. 24.
    Fleury C, Mignotte B, Vayssiere J. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002;84:131–141.PubMedCrossRefGoogle Scholar
  25. 25.
    Li Y, Wu YL. How Chinese scientists discovered qinghaosu (Artemisinin) and developed its derivatives. What are the future perspectives? Med Trop 1998, 58:9–12.Google Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Shokoofe Noori
    • 1
  • Zuhair. M. Hassan
    • 2
  • Vida Farsam
    • 2
  1. 1.Department of Biochemistry, Faculty of MedicineShahid Beheshti University of Medical SciencesTehranIran
  2. 2.Department of Immunology, School of Medical SciencesTarbiat Modares UniversityTehranIran

Personalised recommendations